Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Armenia

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The New England Journal of Medicine|May 29, 1980
Waterskier's enemaR E Kaiser, D Armenia, R Baron, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 12, 2015
A recent epidemiological cluster of acute hepatitis B genotype F1b infection in a restricted geographical area of ItalyM Pollicita, C Alteri, M C Bellocchi, et al.
The Journal of Antimicrobial Chemotherapy|September 24, 2025
Evaluation of HIV-1 DNA resistance evolution in highly treatment-experienced and multi-resistant individuals under suppressive antiretroviral therapy: a longitudinal study from the PRESTIGIO RegistryD Armenia, G Marchegiani, V Spagnuolo, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 12, 2012
The lowest X4 Geno2Pheno false-positive rate is associated with greater CD4 depletion in HIV-1 infected patientsM M Santoro, D Armenia, L Fabeni, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 12, 2023
Temporal trend of drug-resistance and APOBEC editing in PBMC genotypic resistance tests from HIV-1 infected virologically suppressed individualsD Armenia, R Gagliardini, C Alteri, et al.
HIV Medicine|June 30, 2016
Virological response and resistance profile in HIV-1-infected patients starting darunavir-containing regimensD Armenia, D Di Carlo, G Maffongelli, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2016
Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimenD Armenia, D Di Carlo, A Calcagno, et al.
The Journal of Antimicrobial Chemotherapy|February 26, 2015
HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemiaD Armenia, L Fabeni, C Alteri, et al.
The Journal of Antimicrobial Chemotherapy|January 25, 2020
HIV MDR is still a relevant issue despite its dramatic drop over the yearsD Armenia, D Di Carlo, P Flandre, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The New England Journal of Medicine|May 29, 1980
Waterskier's enemaR E Kaiser, D Armenia, R Baron, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 12, 2015
A recent epidemiological cluster of acute hepatitis B genotype F1b infection in a restricted geographical area of ItalyM Pollicita, C Alteri, M C Bellocchi, et al.
The Journal of Antimicrobial Chemotherapy|September 24, 2025
Evaluation of HIV-1 DNA resistance evolution in highly treatment-experienced and multi-resistant individuals under suppressive antiretroviral therapy: a longitudinal study from the PRESTIGIO RegistryD Armenia, G Marchegiani, V Spagnuolo, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 12, 2012
The lowest X4 Geno2Pheno false-positive rate is associated with greater CD4 depletion in HIV-1 infected patientsM M Santoro, D Armenia, L Fabeni, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 12, 2023
Temporal trend of drug-resistance and APOBEC editing in PBMC genotypic resistance tests from HIV-1 infected virologically suppressed individualsD Armenia, R Gagliardini, C Alteri, et al.
HIV Medicine|June 30, 2016
Virological response and resistance profile in HIV-1-infected patients starting darunavir-containing regimensD Armenia, D Di Carlo, G Maffongelli, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2016
Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimenD Armenia, D Di Carlo, A Calcagno, et al.
The Journal of Antimicrobial Chemotherapy|February 26, 2015
HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemiaD Armenia, L Fabeni, C Alteri, et al.
The Journal of Antimicrobial Chemotherapy|January 25, 2020
HIV MDR is still a relevant issue despite its dramatic drop over the yearsD Armenia, D Di Carlo, P Flandre, et al.
Pageof 1